PrintThe Burrill Report (January 11, 2010): New drug approvals improve in 2009 as more biologics get the green light (.MP3,11.84 Mb)
The U.S. Food and Drug Administration approved 26 new drugs in 2009, besting 2008 by a hair, according to Washington Analysis, which provides research to institutional investors. The number of new approvals for small molecule drugs actually fell slightly, while the number of new biologics approved grew. We spoke to Ira Loss, senior health policy analyst with Washington Analysis, about the numbers, whether they reflect a push by Big Pharma into biologics, and whether the FDA under a new administration is faring any better.
.jpg)
.gif)
.gif)
.gif)
